2010
1. Acedo L, Díez-Domingo J, Morano JA, Villanueva RJ. Mathematical modelling of respiratory syncytial virus (RSV): vaccination strategies and budget applications. Epidemiol Infect. 2010 Jun;138(6):853-60.
2. Acedo L, Moraño JA, Díez-Domingo J. Cost analysis of a vaccination strategy for respiratory syncytial virus (RSV) in a network model. Mathematical and Computer Modelling. 2010;52(7-8):1016-22.
3. Cebrián-Cuenca AM, Díez-Domingo J, Rodriguez MS, Puig-Barberá J, Navarro-Perez J. Epidemiology of herpes zoster infection among patients treated in primary care centres in the Valencian community (Spain). BMC Fam Pract. 2010;11:33.
4. Díez-Domingo J, Cantarino MV, Torrenti JM, Sansano MI, Rosich AJ, Merino AH, et al. A randomized, multicenter, open-label clinical trial to assess the immunogenicity of a meningococcal C vaccine booster dose administered to children aged 14 to 18 months. Pediatr Infect Dis J. 2010 Feb;29(2):148-52.
5. Díez-Domingo J, Flores SA, Martin JC, Klopfer SO, Schodel FP, Bhuyan PK. A randomized, multicenter, open-label clinical trial to assess the anamnestic immune response 4 to 8 years after a primary hepatitis B vaccination series. Pediatr Infect Dis J. 2010 Oct;29(10):972-4.
6. Díez-Domingo J, Garces-Sánchez M, Baldo JM, Planelles MV, Ubeda I, JuBert A, et al. Immunogenicity and Safety of H5N1 A/Vietnam/1194/2004 (Clade 1) AS03-adjuvanted prepandemic candidate influenza vaccines in children aged 3 to 9 years: a phase ii, randomized, open, controlled study. Pediatr Infect Dis J. 2010 Jun;29(6):e35-46.
7. Díez-Domingo J, Planelles-Cantarino MV, Baldo-Torrenti JM, Ubeda-Sansano I, Jubert-Rosich A, Puig-Barberá J, et al. Antibody persistence 12 months after a booster dose of meningococcal-C conjugated vaccine in the second year of life. Pediatr Infect Dis J. 2010 Aug;29(8):768-70.
8. Díez-Domingo J, Surinach NL, Alcalde NM, Betegon L, Largeron N, Trichard M. Burden of paediatric Rotavirus Gastroenteritis (RVGE) and potential benefits of a universal Rotavirus vaccination programme with a pentavalent vaccine in Spain. BMC Public Health. 2010;10:469.
9. Díez-Gandía A, Ajenjo MA, Navalon AB, Fernandez RB, Sanz AB, Díez-Domingo J. [Palatability of oral rehydration solutions (ORS) in healthy 6 to 9 year-old children. A multicentre, randomised single blind clinical trial]. An Pediatr (Barc). 2010 Feb;72(2):111-5.
10. Gutierrez-Gimeno MV, Martin-Moreno JM, Díez-Domingo J, Asensi-Botet F, Hernandez-Marco R, Correcher-Medina P, et al. Nosocomial rotavirus gastroenteritis in Spain: a multicenter prospective study. Pediatr Infect Dis J. 2010 Jan;29(1):23-7.
11. Marshall H, Nolan T, Díez Domingo J, Rombo L, Sokal EM, Mares J, et al. Long-term (5-year) antibody persistence following two- and three-dose regimens of a combined hepatitis A and B vaccine in children aged 1-11 years. Vaccine. 2010 Jun 17;28(27):4411-5.
12. Puig-Barberá J, Arnedo-Pena A, Pardo-Serrano F, Tirado-Balaguer MD, Perez-Vilar S, Silvestre-Silvestre E, et al. Effectiveness of seasonal 2008-2009, 2009-2010 and pandemic vaccines, to prevent influenza hospitalizations during the autumn 2009 influenza pandemic wave in Castellon, Spain. A test-negative, hospital-based, case-control study. Vaccine. 2010 Nov 3;28(47):7460-7.
13. Tuells J MPE. Maurice Hilleman (1919-2005), el hombre que inventaba vacunas. Vacunas. 2010;11(1).
14. Tuells J MPE. Mujeres ante la gripe de 1918: la acreditación de las enfermeras. Vacunas. 2010;11(1).